The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management

November 20, 2025 updated by: University Medical Center Groningen

The MuSt-PC: A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs - Feasibility Study

A study on the intent to use a tool (MuSt-PC) to manage symptoms of patients in a palliative care trajectory.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt- PC in daily practice. GHCPs are recruited via the connections of the seven Centers of Expertise in Palliative Care. To invite them to participate in the study, the GHCPs are approached directly via e-mail or telephone. Participating GHCPs will be educated on how to use MuSt-PC (educational materials and instruction webinar). GHCPs will be asked to use the CDSS for five individual patients. Every time after using MuSt-PC they will be asked to answer additional questions about their experience with using MuSt-PC in that specific instance. After using MuSt-PC for five patients, they are requested to fill out a comprehensive questionnaire about their overall experiences with using the CDSS.

Study Type

Observational

Enrollment (Actual)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Groningen, Netherlands
        • University Medical Center Groningen
      • Leiden, Netherlands
        • LUMC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.

Description

Inclusion Criteria:

Residents (in Dutch: Arts In Opleiding tot Specialist (AIOS) or Arts Niet In Opleiding tot Specialist (ANIOS)), medical specialists and nurse practitioners working in the following disciplines are invited to participate:

  • General practice
  • Nursing home
  • Hospital:

    • Clinical geriatrics
    • Medical oncology
    • Radiation oncology
    • Pulmonology
    • Cardiology

Exclusion Criteria:

HCPs who were formally trained in palliative care ("kaderopleiding palliatieve zorg", "Masteropleiding Palliative Medicine for Health Care Professionals at Cardiff University" or "post-HBO opleiding palliatieve zorg") and/or who have been or are currently a consultant of a palliative care consultation team are considered specialists in palliative care, are excluded from participation.

GHCPs (e.g. nurses) who cannot independently decide about CDSS recommendation adherence, including drug interventions, are excluded from participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Arm 1
A targeted sample of healthcare providers (HCPs) who are not specialized in palliative care (GHCPs) constitutes the study population.
A survey study will be conducted to evaluate if GHCPs have the Intention to Use (IU) MuSt-PC in daily practice.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questions evaluating Intention to Use (IU)
Time Frame: after 5 times use of the MuSt-PC tool within 3 months
Questions evaluating Intention to Use (IU) (7-point Likert scales)
after 5 times use of the MuSt-PC tool within 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questions evaluating other modified TAM domains
Time Frame: after 5 times use of the MuSt-PC tool within 3 months
Questions evaluating other modified TAM domains: Perceived Usefulness, Perceived Ease-of-Use, Attitude, Compatibility, Subjective norm, Facilitators, Habit (7-point Likert Scales).
after 5 times use of the MuSt-PC tool within 3 months
Perceived benefits and disadvantages of using MuSt-PC
Time Frame: after 5 times use within 3 months
Perceived benefits and disadvantages of using MuSt-PC (open-ended questions).
after 5 times use within 3 months
Suggestions to improve the MuSt-PC CDSS
Time Frame: after 5 times of the MuSt-PC tool within 3 months
Suggestions to improve the MuSt-PC CDSS (open-ended question).
after 5 times of the MuSt-PC tool within 3 months
An overview of the content of questions of participating GHCPs regarding MuSt-PC use.
Time Frame: after 5 times use within 3 months
An overview of the content of questions of participating GHCPs regarding MuSt-PC use. Questions will be analyzed qualitatively; coding will be done independently by two researchers. In case of disagreement, consensus will be achieved through discussion. Coding will result in categorization of question subject. Categorizations are ranked from most prevalent to least prevalent question subject (proportion of respondents).
after 5 times use within 3 months
Most useful elements of MuSt-PC will be evaluated with a multiple-choice question.
Time Frame: after 5 times use within 3 months
Most useful elements of MuSt-PC will be evaluated with a multiple-choice question. (multiple answers allowed) Frequency and percentage of total respondents who chose the multiple choice answer possibilities will be evaluated
after 5 times use within 3 months
Mean scores of HCPs adherence to CDSS recommendations
Time Frame: after 5 times use of the MuSt-PC tool within 3 months
Mean scores (5-point Likert scale) of HCPs adherence to CDSS recommendations (each time using MuSt-PC)
after 5 times use of the MuSt-PC tool within 3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use
Time Frame: after 5 times use of the MuSt-PC tool within 3 months

A focus group meeting will be conducted if ≥20% of all participating GHCPs have insufficient intention to use MuSt-PC and/or perceive MuSt-PC insufficiently useful and/or perceive MuSt-PC insufficiently easy to use:

  1. Insufficient IU is defined as a sum score of ≤12 for the 3 questions that measure Intention to Use by the modified TAM questionnaire (maximum sum score 21)
  2. Insufficient PU is defined as a sum score of ≤24 for the 6 questions that measure PU by the modified TAM questionnaire (maximum sum score 42)
  3. insufficient PEU is defined as a sum score of ≤24 for the 6 items that measure PEU by the modified TAM questionnaire (maximum sum score 42). (see Appendix G) Six to twelve GHCPs with a sum score of ≤12 (IU) and/or ≤24 (PU and/or PEU) will be invited to participate.
after 5 times use of the MuSt-PC tool within 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: An KL Reyners, MD, PhD, University Medical Center Groningen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 18, 2024

Primary Completion (Actual)

February 28, 2025

Study Completion (Actual)

February 28, 2025

Study Registration Dates

First Submitted

October 7, 2023

First Submitted That Met QC Criteria

October 24, 2023

First Posted (Actual)

October 31, 2023

Study Record Updates

Last Update Posted (Actual)

November 25, 2025

Last Update Submitted That Met QC Criteria

November 20, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Palliative Medicine

Clinical Trials on Survey

Subscribe